State-of-the-art of NORM nuclide determination in samples from oil and gas production: Validation of potential standardization methods through an interlaboratory test programme

Gas and oil companies frequently encounter build-up of Naturally Occurring Radioactive Material (NORM) in their production and processing facilities. In the Netherlands NORM is subject to strict national regulations and, consequently, installations have to be screened on a regular basis. The availability of accurate and reliable NORM sampling and analysis techniques is therefore essential, A number of years ago, the ''Nederlandse Aardolie Maatschappij B.V.'' (NAM) actively Initiated an investigation on analysis techniques for NORM samples from gas and oil companies. Within this framework, Shell Research Amsterdam organized a four-stage interlaboratory test programme in which representative samples of increasing complexity were analyzed by a number of Dutch institutes. Whereas a large spread in results was observed in the first stage, results in the last stage deviated less than +/- 10% from the values certified by all independent referee institute, even for complex sludge samples. It was found that in particular the use of different values for the gamma-yields and branching ratios amongst the institutes was responsible for the initial spread

Targeted intracerebral delivery of the anti-inflammatory cytokine IL13 promotes alternative activation of both microglia and macrophages after stroke

Abstract Background Subtle adjustment of the activation status of CNS resident microglia and peripheral macrophages, to promote their neuroprotective and neuroregenerative functions, may facilitate research towards curing neurodegenerative disorders. In the present study, we investigated whether targeted intracerebral delivery of the anti-inflammatory cytokine interleukin (IL)13, by means of transplanting IL13-expressing mesenchymal stem cells (IL13-MSCs), can promote a phenotypic switch in both microglia and macrophages during the pro-inflammatory phase in a mouse model of ischemic stroke. Methods We used the CX3CR1eGFP/+ CCR2RFP/+ transgenic mouse model to separately recognize brain-resident microglia from infiltrated macrophages. Quantitative immunohistochemical analyses were applied to characterize polarization phenotypes of both cell types. Results Distinct behaviors of both cell populations were noted dependent on the anatomical site of the lesion. Immunohistochemistry revealed that mice grafted with IL13-MSCs, in contrast to non-grafted and MSC-grafted control mice, were able to drive recruited microglia and macrophages into an alternative activation state, as visualized by a significant increase of Arg-1 and a noticeable decrease of MHC-II expression at day 14 after ischemic stroke. Interestingly, both Arg-1 and MHC-II were expressed more abundantly in macrophages than in microglia, further confirming the distinct behavior of both cell populations. Conclusions The current data highlight the importance of controlled and localized delivery of the anti-inflammatory cytokine IL13 for modulation of both microglia and macrophage responses after ischemic stroke, thereby providing pre-clinical rationale for the application of L13-MSCs in future investigations of neurodegenerative disorders